← Back to Search

Perceptual Cuing for Stroke (Bimanual Trial)

N/A

Waitlist Available

Led By Shailesh S Kantak, PhD, PT

Research Sponsored by Albert Einstein Healthcare Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one hour after training

Awards & highlights

Bimanual Trial Summary

This trial looks at how to improve bimanual coordination for those who have had a stroke, in order to make daily activities easier.

Bimanual Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one hour after training

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one hour after training

This trial's timeline: 3 weeks for screening, Varies for treatment, and one hour after training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Spatial coordination measured as cross-correlation coefficient

Time-lag between hands in seconds

Bimanual Trial Design

1Treatment groups

Experimental Treatment

Group I: Perceptual cuingExperimental Treatment1 Intervention

Two perceptual cues will be provided: (a) feedback about the time-lag between the two arms presented as a horizontal tilt of the common goal, and (b) different movement weighting coefficients to each arm to force greater movement contribution of the paretic arm in a bimanual context. The effect of the two cues on bimanual coordination will be determined.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Albert Einstein Healthcare NetworkLead Sponsor

63 Previous Clinical Trials

868,552 Total Patients Enrolled

2 Trials studying Stroke

77 Patients Enrolled for Stroke

University of PennsylvaniaOTHER

2,000 Previous Clinical Trials

42,880,018 Total Patients Enrolled

29 Trials studying Stroke

2,131 Patients Enrolled for Stroke

Shailesh S Kantak, PhD, PTPrincipal InvestigatorMoss Rehabilitation Research Institute

Media Library

Perceptual cuing Clinical Trial Eligibility Overview. Trial Name: NCT03755076 — N/A

Stroke Research Study Groups: Perceptual cuing

Stroke Clinical Trial 2023: Perceptual cuing Highlights & Side Effects. Trial Name: NCT03755076 — N/A

Perceptual cuing 2023 Treatment Timeline for Medical Study. Trial Name: NCT03755076 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do you accept participants aged 25 or older in this trial?

"The minimum age requirement for this clinical trial is 21 years of age, while the upper limit of eligibility sits at 80."

Answered by AI

Is the recruitment period for this study still active?

"According to the information sourced from clinicaltrials.gov, this particular trial is not accommodating new patients at present. Initially posted on April 19th 2019 and last updated July 25th 2022, it does not seem to be recruiting any more test subjects for now; however there are 1,044 other medical studies actively enrolling participants currently."

Answered by AI

Who should be considered for participation in this scientific experiment?

"This trial is seeking 70 stroke patients aged 21 to 80. Candidates must be able to extend their arm along a diagonal axis at least 80% of its length while supported on an immobile surface and with limited trunk movement, possess a minimum Mini-Mental scale score of 26 or higher, OR have achieved a level 4 or above in the auditory verbal comprehension portion of the Western Aphasia Battery as evidence of adequate understanding and command following ability."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Perceptual-motor Interaction to Improve Bimanual Coordination After Stroke

Shailesh Kantak 2019. "Perceptual-motor Interaction to Improve Bimanual Coordination After Stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03755076.